Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
N. Kappelmann et al.
MOLECULAR PSYCHIATRY (2018)
Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Cristiano A. Kohler et al.
MOLECULAR NEUROBIOLOGY (2018)
Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis
S. P. Leighton et al.
MOLECULAR PSYCHIATRY (2018)
Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis
Magdalena Wiedlocha et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice
Vicente Lieberknecht et al.
MOLECULAR NEUROBIOLOGY (2017)
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation
Andrew H. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Jennifer C. Felger et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
Manish K. Jha et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial
Bharathi S. Gadad et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis
Muhammad I. Husain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Is C-reactive protein ready for prime time in the selection of antidepressant medications?
Andrew H. Miller et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
Manish K. Jha et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
Christopher E. M. Griffiths et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection
Manish K. Jha et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
Ole Kohler-Forsberg et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
Manish K. Jha et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Hepatitis C treatment: where are we now?
Nicholas J. Burstow et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-NIED Trial
Manish K. Jha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression
Jan Fawcett et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Jennifer L. Remus et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Depression Is Associated With High Levels of C- Reactive Protein and Low Levels of Fractional Exhaled Nitric Oxide: Results From the 2007-2012 National Health and Nutrition Examination Surveys
M. Soledad Cepeda et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States
Melissa J. Danesh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Mapping inflammation onto mood: Inflammatory mediators of anhedonia
Walter Swardfager et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
Manish K. Jha et al.
PLOS ONE (2016)
Right patient, right treatment, right time: biosignatures and precision medicine in depression
Madhukar H. Trivedi
WORLD PSYCHIATRY (2016)
Association of Systemic Inflammation With Risk of Completed Suicide in the General Population
G. David Batty et al.
JAMA PSYCHIATRY (2016)
Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial
Nga T. T. Do et al.
LANCET GLOBAL HEALTH (2016)
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
Benjamin Farahnik et al.
DERMATOLOGY AND THERAPY (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
Bruce A. Arnow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Inflammation: Depression Fans the Flames and Feasts on the Heat
Janice K. Kiecolt-Glaser et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Restarting antidepressant treatment following early discontinuation-a primary care database study
Christopher Burton et al.
FAMILY PRACTICE (2015)
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: A CO-MED report
Sharon C. Sung et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjunctive L-Methylfolate Calcium in Patients With MDD Who Are Inadequate Responders to SSRIs
Richard C. Shelton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Paul E. Greenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug
Charlie Schmidt
NATURE BIOTECHNOLOGY (2015)
IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder
C. D. Rethorst et al.
TRANSLATIONAL PSYCHIATRY (2015)
RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response
J. M. Hennings et al.
TRANSLATIONAL PSYCHIATRY (2015)
Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior
Eric S. Wohleb et al.
FRONTIERS IN NEUROSCIENCE (2015)
An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample
Silke Kern et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress
Georgia E. Hodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
Kyoung-Sae Na et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996-2013
David A. Mrazek et al.
PSYCHIATRIC SERVICES (2014)
From Stress to Inflammation and Major Depressive Disorder: A Social Signal Transduction Theory of Depression
George M. Slavich et al.
PSYCHOLOGICAL BULLETIN (2014)
What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment
Susan Ball et al.
ANNALS OF GENERAL PSYCHIATRY (2014)
Inflammatory T Helper 17 Cells Promote Depression-like Behavior in Mice
Eleonore Beurel et al.
BIOLOGICAL PSYCHIATRY (2013)
Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies
Yafang Huang et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2013)
Gender differences in the relationship between symptoms of depression and high-sensitivity CRP
M. L. Vetter et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
Vyara Valkanova et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Citalopram suppresses thymocyte cytokine production
Aparna R. Shenoy et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder
C. D. Rethorst et al.
MOLECULAR PSYCHIATRY (2013)
What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn
Kenneth S. Kendler
MOLECULAR PSYCHIATRY (2013)
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report
S. C. Sung et al.
PSYCHOLOGICAL MEDICINE (2013)
Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73131 Individuals
Marie Kim Wium-Andersen et al.
JAMA PSYCHIATRY (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
IL-17 cytokines in immunity and inflammation
Wei Jin et al.
EMERGING MICROBES & INFECTIONS (2013)
The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses
Matthias Ebbinghaus et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Matteo Martino et al.
CURRENT NEUROPHARMACOLOGY (2012)
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
Edward S. Friedman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations
Sharon C. Sung et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine
Marcia D. McNutt et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
S. A. Hiles et al.
PSYCHOLOGICAL MEDICINE (2012)
Is There Anything Really Novel on the Antidepressant Horizon?
James W. Murrough et al.
CURRENT PSYCHIATRY REPORTS (2012)
The Depression Treatment Cascade in Primary Care: A Public Health Perspective
Brian W. Pence et al.
CURRENT PSYCHIATRY REPORTS (2012)
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder An Updated Meta-analysis
Gerald Gartlehner et al.
ANNALS OF INTERNAL MEDICINE (2011)
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
William V. Bobo et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder: A Randomized, Parallel Dose Comparison
Madhukar H. Trivedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans
Jennifer L. Warner-Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells
Yili Chen et al.
PSYCHIATRY RESEARCH (2011)
Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders
Thomas Insel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Naomi I. Eisenberger et al.
BIOLOGICAL PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Jula Huppert et al.
FASEB JOURNAL (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity
Daniel Lindqvist et al.
BIOLOGICAL PSYCHIATRY (2009)
What predicts attrition in second step medication treatments for depression?: a STAR*D Report
Diane Warden et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis
Jayasri Das Sarma et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
Production and functions of IL-17 in microglia
Jun Kawanokuchi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
TH 17 cells in development:: an updated view of their molecular identity and genetic programming
Chen Dong
NATURE REVIEWS IMMUNOLOGY (2008)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
A new chapter opens in anti-inflammatory treatments: The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice
D. Brustolim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
AJ Rush et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Medication augmentation after the failure of SSRIs for depression
MH Trivedi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Epidemiology of major depressive disorder - Results from the National Epidemiologic Survey on Alcoholism and Related Conditions
DS Hasin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C
CL Raison et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
CL Raison et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Extent of regression dilution for established and novel coronary risk factors: Results from the British Regional Heart Study
JR Emberson et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2004)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quality of life assessments in Major Depressive Disorder: a review of the literature
GI Papakostas et al.
GENERAL HOSPITAL PSYCHIATRY (2004)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Psychosocial disability during the long-term course of unipolar major depressive disorder
LL Judd et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
